Large-scale testing (Phase 3)Study completedNCT00485732
What this trial is testing
Evaluate the Immune Response and Safety of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine/Cervarix TM Vaccine in Healthy Females Aged 15-25 Years
Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 225